Accessed 24 November 2017
Damit wir die Meilensteine der Strategie des Globalen
Fonds für 2028 einhalten können und SDG 3 für uns weiter
erreichbar bleibt, benötigen wir 18 Milliarden US-Dollar,
um die nächste dreijährige Förderperiode des Globalen
Fonds finanzieren zu können.
Dies ist ein entscheidender Moment bei der Bekämpfung von HIV, Tuberkulose (TB) und Malaria. Für unsere achte Wiederauffüllung benötigt der Globale Fonds 18 Milliarden US-Dollar, um 23 Millionen Menschenleben zu retten, die Sterberate der drei Krankheiten um 64 % zu senken und am Aufbau einer We...lt mitzuwirken, die gesünder, sicherer und gerechter ist.
more
Development assistance for health (DAH) is an important source of financing for health for many low-income and some middle-income countries. Most DAH has predominantly been contributed by high-income countries. However, in the context of economic progress and changing global priorities, DAH contribu...tions from countries of the Global South such as India have gained importance. In this paper, we estimate DAH contributed by India between 2009 and 2020.
more
Dieses Dokument stellt aktuelle Ergebnisse zum Thema Official Development Assistance (ODA) mit Fokus auf Gesundheit und Deutschland zur Verfügung.
The webpage from Medicines for Malaria Venture (MMV) focuses on efforts to develop and provide child-friendly antimalarial treatments. It highlights the challenges of treating malaria in children, who are among the most vulnerable to the disease, and the need for safe, effective, and easy-to-adminis...ter formulations. MMV collaborates with global partners to ensure access to pediatric antimalarial medicines, such as dispersible tablets and rectal treatments, especially in low-resource settings. The page emphasizes the importance of innovation, accessibility, and partnerships in reducing childhood malaria mortality.
more
This document is designed to assist UNICEF and WHO country offices in collaborating with national, sub-national, and
local counterparts to implement the UNICEF Game Plan to Reach Safely Managed Sanitation 2022–2030 and the WHO
Guidelines on sanitation and health. It also aims to facilitate compl...ementary activities by sector partners towards shared
goals. The implementation steps outlined here promote greater alignment of sanitation activities among UNICEF, WHO,
and other stakeholders, including UN agencies, civil society, the private sector, and academia
more
Dieses Dokument bietet eine Problemanalyse der US-Kürzungen im Bereich globale Gesundheit und leitet daraus konkrete Handlungsempfehlungen für medizinische Akteure ab. Im Fokus steht die Analyse der direkten Auswirkungen auf die gesundheitsspezifische Entwicklungszusammenarbeit.
Efficacious antimalarial medicines are critical to malaria control and elimination. Continuous monitoring of their efficacy is needed to inform treatment policies in malaria-endemic countries, and to ensure early detection of, and response to, drug resistance.
Respiratory viruses are viruses that cause illnesses in the respiratory system. These illnesses share similar symptoms, risk factors, and prevention strategies.
EXPERT OPINION ON DRUG SAFETY 2018, VOL. 17, NO. 11, 1129–1144.
Malaria during and after pregnancy contributes significantly to maternal mortality and adverse fetal outcomes. While effective and safe antimalarial treatments are essential, quinine — an older, less effective drug — has long bee...n favoured due to the limited safety data available on newer drugs. This review summarises the results of human studies investigating the safety and efficacy of antimalarial drugs during pregnancy and lactation.
more
Infection and Drug Resistance 2020:13 4047–4060
This Implementation Kit (I-Kit) is designed to support SBCC and Malaria in Pregnancy (MiP) programme managers in improving their communication strategies, particularly those targeting healthcare workers. It provides practical guidance on four key planning areas and emphasises the significant health ...risks that malaria poses to mothers and newborns. The I-Kit highlights evidence-based WHO interventions and addresses barriers to access, demand and the delivery of MiP services by providers. Despite progress in reducing malaria, uptake of preventive measures remains low, highlighting the need for targeted advocacy and improved SBCC strategies.
more
Int. J. Transl. Med. 2023, 3(2), 187-202; https://doi.org/10.3390/jtm3020014 .
Malaria and HIV are geographically in the tropics and subtropics of the world, including sub-Saharan Africa. Understanding the overlapping effect of both infections, especially among pregnant women, is crucial in managin...g pregnant women during antenatal care visits, and postpartum babies. It was realized that the prevalence of malaria among HIV-positive pregnant women ranges between 31–61%, while for non-HIV infected pregnant women the prevalence still stands between 10 and 36%. Co-infection is between 0.52 and 56.3%.
more
The Global Malaria Programme Toolkit app brings together the content of the latest World malaria report and of the consolidated WHO Guidelines for malaria as well as operational manuals and other technical documents – in one easy-to-navigate resource.
Lancet Glob Health 2023; 11: e1805–18
You can download the modules from the website